A Philadelphia jury returned a $34 million verdict Monday against two drugmakers over hormone-replacement therapy drugs that the jury found caused a plaintiff's breast cancer. And a $75 million punitive damages verdict from the end of October in another hormone-replacement therapy, or HRT, mass tort case was unsealed by court order after the other jury verdict was rendered around 2 p.m. Monday.
Drugmakers Get Double Dose of Bad News Over Hormone-Replacement Therapy Products
The Legal Intelligencer
November 24, 2009